National Biopharma Mission Current Affairs, GK & News

First CAR-T Cell Therapy Conducted

Clinical trials of Chimeric Antigen Receptor T-cell (CAR-T) therapy was conducted globally. Therapy has emerged as a breakthrough in cancer treatment. It has shown promising results on end stage patients, especially in patients of Acute Lymphocytic Leukemia. Highlights CAR-T technology has a remarkable therapeutic potential for cancer patients. This technology is not available in India, ..

Month: 

Category: 

Topics: 

National Biopharma Mission- Highlights

Department of Biotechnology (DBT) has initiated cabinet approved National Biopharma Mission with the objective of strengthening emerging biotechnology enterprise across India. Mission is entitled as “Industry-Academia Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals – Innovate in India (I3) Empowering biotech entrepreneurs & accelerating inclusive innovation”. National Biopharma Mission National Biopharma mission ..

Month: 

Category: 

Topics: 

Mission COVID Suraksha launched

The Government of India recently launched Mission COVID Suraksha to accelerate development of vaccine in the country. It will ensure that the vaccines being developed are brought closer to the market. The mission was introduced by Finance Minister Nirmala Sitharaman on November 12, 2020 as a part of 12 announcements made under Atma Nirbhar Bharat ..

Month: 

Category: 

Topics: 

BioAsia Summit 2020 to be held in Hyderabad

The Government of Telangana is hosting Bio-Asia Summit 2020 in Hyderabad between February 17, 2020 and February 19, 2020. The main objective of the summit is to explore the capabilities of Life Science Companies and their investments. Highlights The summit will be attended by researchers, investors, conglomerates, start-ups and health care representatives. They will focus ..

Month: 

Category: 

Topics: 

National Biopharma Mission

The National Biopharma Mission was established in the year 2017 with an aim to accelerate the biopharmaceutical development in India. The program also named Innovate in India (i3) was host to an investment of USD 250 million with half of the amount coming as a loan from World Bank. The National Biopharma Mission aims to ..

Topics: